NICE rejects belimumab for lupus

[Jenny]

http://www.guardian.co.uk/business/2012/apr/27/drug-company-nice-lupus-reject

Doesn't bode well for us if rituximab works out.

Jenny

 

[Esther12]

Isn't rituximab out of patent soon? I think this is one of the reasons why there is little funding for trials. If it's shown to be effective, then it should be available cheaply soon after.

 

[Enid]

Well they are into NHS spending aren't they - what more can you expect.

 

[Snow Leopard]

30,000 per QALY they say.

The following study on CBT for CFS had a QALY of 0.03, after 16 sessions. Cost per patient is about 2000 Euros, or 1600 GBP.
http://www.biomedcentral.com/1472-6963/8/175

1/0.03 x 1600 = over 50,000 GBP, which means CBT is NOT COST EFFECTIVE ACCORDING TO THE NICE GUIDELINES and the data from this paper.

If they want to reject this drug for Lupus on this basis, then they have some explaining to do...

 

[Jenny]

Interesting calculation Snow!

 

[Esther12]

30,000 per QALY they say.

The following study on CBT for CFS had a QALY of 0.03, after 16 sessions. Cost per patient is about 2000 Euros, or 1600 GBP.
http://www.biomedcentral.com/1472-6963/8/175

1/0.03 x 1600 = over 50,000 GBP, which means CBT is NOT COST EFFECTIVE ACCORDING TO THE NICE GUIDELINES and the data from this paper.

If they want to reject this drug for Lupus on this basis, then they have some explaining to do...

Is the CNT QALY thought to be per year, and with lasting results?

 

[Snow Leopard]

Is the CNT QALY thought to be per year, and with lasting results?

All I'm going to say right now is: that is a good question.